Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer

Detalles Bibliográficos
Autores principales: Mace, Thomas, Shakya, Reena, Pitarresi, Jason, Loftus, Shannon, Swanson, Benjamin, Young, Gregory, Zhong, Xioling, Zimmers, Teresa, Ostrowski, Michael, Ludwig, Thomas, Bloomston, Mark, Bekaii-Saab, Tanios, Lesinski, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649353/
http://dx.doi.org/10.1186/2051-1426-3-S2-P366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649353/
http://dx.doi.org/10.1186/2051-1426-3-S2-P366

Ejemplares similares